311 related articles for article (PubMed ID: 28288718)
21. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
[TBL] [Abstract][Full Text] [Related]
22. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
23. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
[TBL] [Abstract][Full Text] [Related]
24. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
[TBL] [Abstract][Full Text] [Related]
26. NF-κB deregulation in splenic marginal zone lymphoma.
Spina V; Rossi D
Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
[TBL] [Abstract][Full Text] [Related]
27. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
Kiel MJ; Velusamy T; Betz BL; Zhao L; Weigelin HG; Chiang MY; Huebner-Chan DR; Bailey NG; Yang DT; Bhagat G; Miranda RN; Bahler DW; Medeiros LJ; Lim MS; Elenitoba-Johnson KS
J Exp Med; 2012 Aug; 209(9):1553-65. PubMed ID: 22891276
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA losses in the frequently deleted region of 7q in SMZL.
Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
[No Abstract] [Full Text] [Related]
31. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
[TBL] [Abstract][Full Text] [Related]
32. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
Spina V; Rossi D
Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
[TBL] [Abstract][Full Text] [Related]
34. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
35. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
[TBL] [Abstract][Full Text] [Related]
36. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
37. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
[TBL] [Abstract][Full Text] [Related]
38. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
[TBL] [Abstract][Full Text] [Related]
39. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract][Full Text] [Related]
40. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
